IDC Names ZS a Leader in Life Sciences Evidence Services

Sep 20, 2026
ZS was named a Leader in a 2026 IDC MarketScape assessment of life sciences research and development services for real world data and evidence.
IDC Names ZS a Leader in Life Sciences Evidence Services

ZS said in a press release that it was named a Leader in a 2026 IDC MarketScape assessment. The report evaluates life sciences research and development providers offering real world data, evidence platforms, technology and consulting services.

The assessment cited the company's Medical and Evidence practice, ZAIDYN Medical platform, Patient Radar platform, ZS Data Nexus and Evidence Pro. ZS reported a 90% net promoter score and 97% client retention for its real world data and evidence work.

ZS said it has delivered more than 250 integrated evidence plans. The company also said its process increased output from one plan completed in four to five months to more than 30 plans completed in 10 weeks.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.